Authors:
STEINER T
BLUHMKI E
KASTE M
TONI D
TROUILLAS P
VONKUMMER R
HACKE W
Citation: T. Steiner et al., THE ECASS 3-HOUR COHORT - SECONDARY ANALYSIS OF ECASS DATA BY TIME STRATIFICATION, Cerebrovascular diseases, 8(4), 1998, pp. 198-203
Authors:
BOGOUSSLAVSKY J
DEKEYSER J
DIENER HC
FIESCHI C
HACKE W
KASTE M
ORGOGOZO JM
PULSINELLI W
WAHLGREN NG
Citation: J. Bogousslavsky et al., NEUROPROTECTION AS INITIAL THERAPY IN ACUTE STROKE - 3RD REPORT OF ANAD HOC CONSENSUS GROUP MEETING, Cerebrovascular diseases, 8(1), 1998, pp. 59-72
Authors:
AALTOSETALA K
PALOMAKI H
MIETTINEN H
VUORIO A
KUUSI T
RAININKO R
SALONEN O
KASTE M
KONTULA K
Citation: K. Aaltosetala et al., GENETIC RISK-FACTORS AND ISCHEMIC CEREBROVASCULAR-DISEASE - ROLE OF COMMON VARIATION OF THE GENES ENCODING APOLIPOPROTEINS AND ANGIOTENSIN-CONVERTING ENZYME, Annals of medicine, 30(2), 1998, pp. 224-233
Citation: I. Asikainen et al., PREDICTING LATE OUTCOME FOR PATIENTS WITH TRAUMATIC BRAIN INJURY REFERRED TO A REHABILITATION PROGRAM - A STUDY OF 508 FINNISH PATIENTS 5 YEARS OR MORE AFTER INJURY, Brain injury, 12(2), 1998, pp. 95-107
Authors:
HACKE W
KASTE M
FIESCHI C
VONKUMMER R
DAVALOS A
MEIER D
LARRUE V
BLUHMKI E
DAVIS S
DONNAN G
SCHNEIDER D
DIEZTEJEDOR E
TROUILLAS P
Citation: W. Hacke et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF THROMBOLYTIC THERAPY WITH INTRAVENOUS ALTEPLASE IN ACUTE ISCHEMIC STROKE (ECASS-II), Lancet, 352(9136), 1998, pp. 1245-1251
Authors:
HILLBOM M
ERILA T
FLOSBACH C
SOTANIEMI K
TATLISUMAK T
SARNA S
KASTE M
Citation: M. Hillbom et al., ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, IS SUPERIOR TO HEPARIN INTHE PREVENTION OF DEEP-VEIN THROMBOSIS IN STROKE PATIENTS, Stroke, 29(1), 1998, pp. 8-8
Authors:
KASTE M
MAU J
BLUHMKI E
DELZOPPO GJ
ORGOGOZO JM
OVERGAARD K
VONKUMMER R
WAHLGREN NG
Citation: M. Kaste et al., RISK BENEFIT ASSESSMENT FOR MORTALITY AND HANDICAP IN 615 ECASS RANDOMIZED AND TREATED PATIENTS - A POST-HOC ANALYSIS/, Stroke, 29(1), 1998, pp. 81-81
Authors:
KARTTUNEN V
VENTILA M
HILLBOM M
SALONEN O
HAAPANIEMI H
KASTE M
Citation: V. Karttunen et al., DYE DILUTION AND OXIMETRY FOR DETECTION OF PATENT FORAMEN OVALE, Acta neurologica Scandinavica, 97(4), 1998, pp. 231-236
Authors:
ASPLUND K
BERMAN P
BLOMSTRAND C
DENNIS M
DOUGLAS J
ERILA T
GARRAWAY M
HAMRIN E
HANKEY G
ILMAVIRTA M
INDREDAVIK B
KALRA L
KASTE M
LANGHORNE P
RODGERS H
SIVENIUS J
SLATTERY J
STEVENS R
SVENSSON A
WARLOW C
WILLIAMS B
WOODDAUPHINEE S
Citation: K. Asplund et al., COLLABORATIVE SYSTEMATIC REVIEW OF THE RANDOMIZED TRIALS OF ORGANIZEDINPATIENT (STROKE UNIT) CARE AFTER STROKE, BMJ. British medical journal, 314(7088), 1997, pp. 1151-1159
Authors:
KEKOMAKI S
HAMALAINEN I
KASTE M
KAUPPINENMAKELIN R
MIETTINEN H
PALOMAKI H
KONTULA K
Citation: S. Kekomaki et al., PLATELET FIBRINOGEN RECEPTOR POLYMORPHISM HPA-1 IN ACUTE MYOCARDIAL-INFARCTION AND ACUTE ISCHEMIC STROKE, Thrombosis and haemostasis, 1997, pp. 1041-1041
Authors:
POHJASVAARA T
ERKINJUNTTI T
VATAJA R
KASTE M
Citation: T. Pohjasvaara et al., COMPARISON OF STROKE FEATURES AND DISABILITY IN DAILY-LIFE IN PATIENTS WITH ISCHEMIC STROKE AGED 55 TO 70 AND 71 TO 85 YEARS, Stroke, 28(4), 1997, pp. 729-735
Authors:
POHJASVAARA T
ERKINJUNTTI T
VATAJA R
KASTE M
Citation: T. Pohjasvaara et al., DEMENTIA 3 MONTHS AFTER STROKE - BASE-LINE FREQUENCY AND EFFECT OF DIFFERENT DEFINITIONS OF DEMENTIA IN THE HELSINKI STROKE AGING MEMORY STUDY (SAM) COHORT, Stroke, 28(4), 1997, pp. 785-792
Authors:
ASPLUND K
BERMAN P
BLOMSTRAND C
DENNIS M
ERILA T
GARRAWAY M
HAMRIN E
HANKEY G
ILMAVIRTA M
INDREDAVIK B
KALRA L
KASTE M
LANGHORNE P
RODGERS H
SIVENIUS J
SLATTERY J
STEVENS R
SVENSSON A
WARLOW C
WILLIAMS B
WOODDAUPHINEE S
DELEO D
DRUMMOND A
FOGELHOLM R
LINCOLN N
PALOMAKI H
STRAND T
WILHELMSEN L
COUNSELL C
FRASER H
Citation: K. Asplund et al., HOW DO STROKE UNITS IMPROVE PATIENT OUTCOMES - A COLLABORATIVE SYSTEMATIC REVIEW OF THE RANDOMIZED TRIALS, Stroke, 28(11), 1997, pp. 2139-2144